Skip to main content
Clinical Trials/JPRN-UMIN000005331
JPRN-UMIN000005331
Completed
Phase 4

Comparison of the effect on vascular endothelial function and systemic metabolism between Liraglutide and insulin Glargine in patients with type 2 diabetes -prospective randomized controlled trial- - Study for the effects of Liraglutide on vascular endothelial function and systemic metabolism in patients with type 2 diabetes

Hokkaido University Hospital0 sites30 target enrollmentMarch 28, 2011

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Hokkaido University Hospital
Enrollment
30
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 28, 2011
End Date
December 31, 2013
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) patients who received insulin injection therapy, 2\) severe hepatic dysfunction, renal dysfunction, heart failure, 3\) history of angina, myocardial infarction, stroke or other arteriosclerotic diseases, 4\) patients who receive more than three antihypertensive agents, 5\) patients who receive more than two antidyslipidemia agents, 6\) history of anaphylaxis of liragrutide or insulin glargine, 7\) pregnancy, 8\) patients who are inadequate to enter this study due to the other reasons by physician's judgments

Outcomes

Primary Outcomes

Not specified

Similar Trials